{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Brooklyn Ctr",
      "state": "MN",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97796",
      "recalling_firm": "Mohamed Hagar",
      "address_1": "4952 Highway 169 N",
      "address_2": "N/A",
      "postal_code": "55428-4026",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0396-2026",
      "product_description": "Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0",
      "product_quantity": "125 boxes",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).",
      "recall_initiation_date": "20251008",
      "center_classification_date": "20260317",
      "report_date": "20260311",
      "code_info": "ALL LOTS, exp 12/31/2027"
    }
  ]
}